Lead Therapeutics captures $3M for cancer treatments
Lead Therapeutics, developer of medications for cancer and other infectious diseases, has roped $3 million of an expected $7 million round of debt and rights, reports VentureWire. Based in San Bruno, Calif., it previously brought in $17 million in a first round of venture funding in 2007 from Mustang Ventures, Pappas Ventures and ProQuest Investments. The company conducts most of its research and operations in China.
Tiandi Energy raises $2.5M for specialized outsourcing
When people think of outsourcing they generally imagine manufacturing or call centers taking place somewhere far away. However, some startups are tapping into more highly educated workforces overseas.
Tiandi Energy locates people with advanced geotechnical knowledge from China, bringing them into the lucrative — but understaffed — Western oil and gas industry.
As technical jobs markets continue to boom in the United States and other affluent countries, similar staffing gaps are likely to develop in quite a… Continue Reading
Life sciences briefing: Tuesday, Nov. 6, 2007
Featured companies: Ganeden Biotech, Glenveigh Medical, Lab21, Lead Therapeutics, Navigenics, Pacific Data Designs, PharMEDium Healthcare, Sloning BioTechnology, VistaGen
UPDATED: Expanded items on Lead Therapeutics, Glenveigh Medical and Sloning BioTech, and moved the Navigenics news to a separate item here.
Lead Therapeutics raises $17M for China-based work in cancer and immunology — San Bruno, Calif.-based Lead Therapeutics, a drug-development startup that plans to do most of its research and development in China, raised $17 million in a first funding round…. Continue Reading